Sequenom Center for Molecular Medicine Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Sequenom Center for Molecular Medicine General Information
Description
Operator of a diagnostics laboratory. The company offers a range of molecular genetic laboratory tests and test for age related macular degeneration.
Contact Information
Website
www.cmmdx.orgCorporate Office
- 301 Michigan Street North East
- Suite 580
- Grand Rapids, MI 49503
- United States
Corporate Office
- 301 Michigan Street North East
- Suite 580
- Grand Rapids, MI 49503
- United States
Sequenom Center for Molecular Medicine Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sequenom Center for Molecular Medicine Patents
Sequenom Center for Molecular Medicine Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2015252141-A1 | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses | Inactive | 16-Sep-2009 | ||
| AU-2019257485-B2 | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses | Active | 16-Sep-2009 | 0 | |
| AU-2017251674-B2 | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses | Active | 16-Sep-2009 | 0 | |
| AU-2022203662-A1 | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses | Pending | 16-Sep-2009 | ||
| AU-2017251674-A1 | Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses | Active | 16-Sep-2009 |
Sequenom Center for Molecular Medicine Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Sequenom Center for Molecular Medicine FAQs
-
When was Sequenom Center for Molecular Medicine founded?
Sequenom Center for Molecular Medicine was founded in 2007.
-
Where is Sequenom Center for Molecular Medicine headquartered?
Sequenom Center for Molecular Medicine is headquartered in Grand Rapids, MI.
-
What industry is Sequenom Center for Molecular Medicine in?
Sequenom Center for Molecular Medicine’s primary industry is Laboratory Services (Healthcare).
-
Is Sequenom Center for Molecular Medicine a private or public company?
Sequenom Center for Molecular Medicine is a Private company.
-
What is the current valuation of Sequenom Center for Molecular Medicine?
The current valuation of Sequenom Center for Molecular Medicine is 000.
-
What is Sequenom Center for Molecular Medicine’s current revenue?
The current revenue for Sequenom Center for Molecular Medicine is 000000.
-
Who are Sequenom Center for Molecular Medicine’s investors?
Corewell Health and Van Andel Institute have invested in Sequenom Center for Molecular Medicine.
-
When was Sequenom Center for Molecular Medicine acquired?
Sequenom Center for Molecular Medicine was acquired on 17-Nov-2008.
-
Who acquired Sequenom Center for Molecular Medicine?
Sequenom Center for Molecular Medicine was acquired by Sequenom.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
